Clinical Trials Browser

Phase 2 × Lung Neoplasms × Aspirin × Clear all

NCT03654105 2024-03-07

SMILE

Phase 2 Active not recruiting

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation